SCHEMBL8040682

SCHEMBL8040682

Cc1c(O)noc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL402583 0.72
Hydrochloric Acid SCHEMBL28751278 0.70
SCHEMBL25042524 0.69
SCHEMBL3299738 0.68
SCHEMBL573503 0.65 NPC1 (0.32)
SCHEMBL1695121 0.65 MLYCD (0.38)
SCHEMBL738718 0.64 ESR1 (0.34)
SCHEMBL6294438 0.64 MLYCD (0.40)
SCHEMBL2428653 0.62 MLYCD (0.33)
SCHEMBL7856723 0.62 PDE10A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1656079-A Pyrazole compounds and pharmaceutical compositions containing the same EISAI CO LTD (JP) 2005-08-17 CN disclosed
CN-1617676-A Method of fattening poultry AJINOMOTO KK (JP) 2005-05-18 CN disclosed
US-6132724-A Allelic polygene diagnosis of reward deficiency syndrome and treatment CITY OF HOPE NATIONAL MEDICAL CENTER (US) 2000-10-17 US disclosed
EP-0979092-A2 ALLELIC POLYGENE DIAGNOSIS OF REWARD DEFICIENCY SYNDROME AND TREATMENT Kenneth Blum, Inc. (US) 2000-02-16 EP disclosed
WO-1998048785-A9 ALLELIC POLYGENE DIAGNOSIS OF REWARD DEFICIENCY SYNDROME AND TREATMENT KENNETH BLUM INC (US) 1999-05-20 WO disclosed
WO-1998048785-A2 ALLELIC POLYGENE DIAGNOSIS OF REWARD DEFICIENCY SYNDROME AND TREATMENT KENNETH BLUM, INC. (US) 1998-11-05 WO disclosed
EP-0381696-B1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COCAINE ADDICTION MATRIX TECHNOLOGIES, INC. (US) 1993-07-28 EP disclosed
US-5189064-A Administering enkephalinase inhibitor and neurotransmitter precursor MATRIX TECHNOLOGIES, INC. (US) 1993-02-23 US disclosed